Backed by
Hong Kong Science and Technology Park
Milestones, partnerships, and media coverage.
We are excited to announce that Eve Fertility has advanced to the next stage of the MedTech Innovator Asia Pacific 2026 Accelerator Program – the world’s largest MedTech accelerator.
We have been invited to pitch in person at the MedTech Innovator Pitch Event in Singapore on 14–15 April 2026. This is an opportunity to present our vision for making fertility care affordable across APAC to a curated audience of investors, industry leaders, and strategic partners.
MedTech Innovator’s Asia Pacific program has a strong track record of supporting early‑stage companies that address critical healthcare challenges. We are honoured to be part of this cohort and look forward to connecting with the MedTech community in Singapore.
More details on the program can be found on the MedTech Innovator website.
We are proud to announce that Eve Fertility has been selected as one of the Top 10 finalists for the Alpha Startups™ INNO4HER 2026 FemTech Accelerator, organised by 1337 Ventures.
Selected from a highly competitive pool of global applicants, the cohort represents startups from Malaysia, Singapore, Hong Kong, the Philippines, and Poland. The programme focuses on innovations that improve women’s health, with a strong emphasis on clinical depth and structural impact.
“It is encouraging to see founders pushing the boundaries of what FemTech can achieve for the future of global healthcare,” said Bikesh Lakhmichand, CEO and Founding Partner of 1337 Ventures.
Eve Fertility’s inclusion in the programme recognises our mission to make fertility care more affordable and accessible across APAC through IVC technology. The accelerator has provided mentorship from industry experts, and we are excited to pitch at the Demo Day on 31 March 2026 at Microsoft Malaysia.
You can read the full announcement on Disruptr.